Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.80)
# 3,116
Out of 4,749 analysts
60
Total ratings
53.57%
Success rate
-6.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Overweight | $13 → $10 | $5.63 | +77.62% | 5 | Jan 21, 2025 | |
| OMCL Omnicell | Maintains: Equal-Weight | $49 → $40 | $44.99 | -11.09% | 12 | Jan 13, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $41 → $43 | $59.10 | -27.24% | 9 | Jan 13, 2025 | |
| AMWL American Well | Upgrades: Overweight | $15 | $10.78 | +39.15% | 3 | Jan 13, 2025 | |
| VEEV Veeva Systems | Maintains: Overweight | $275 → $285 | $233.26 | +22.18% | 5 | Dec 6, 2024 | |
| ACCD Accolade | Maintains: Equal-Weight | $7 → $6 | $6.89 | -12.92% | 10 | Oct 11, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $107 → $110 | $110.42 | -0.38% | 8 | Jun 20, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Overweight | $10 | $4.77 | +109.64% | 6 | Mar 25, 2024 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $28 → $23 | $10.16 | +126.38% | 2 | Mar 6, 2023 |
Health Catalyst
Jan 21, 2025
Maintains: Overweight
Price Target: $13 → $10
Current: $5.63
Upside: +77.62%
Omnicell
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $49 → $40
Current: $44.99
Upside: -11.09%
Doximity
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $41 → $43
Current: $59.10
Upside: -27.24%
American Well
Jan 13, 2025
Upgrades: Overweight
Price Target: $15
Current: $10.78
Upside: +39.15%
Veeva Systems
Dec 6, 2024
Maintains: Overweight
Price Target: $275 → $285
Current: $233.26
Upside: +22.18%
Accolade
Oct 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $6.89
Upside: -12.92%
HealthEquity
Jun 20, 2024
Maintains: Overweight
Price Target: $107 → $110
Current: $110.42
Upside: -0.38%
GoodRx Holdings
Mar 25, 2024
Upgrades: Overweight
Price Target: $10
Current: $4.77
Upside: +109.64%
Teladoc Health
Mar 6, 2023
Maintains: Equal-Weight
Price Target: $28 → $23
Current: $10.16
Upside: +126.38%